Biography

1. Research Interest

I am mainly engaged in the clinical and basic study of urological tumors.In 2014 I presided over the topic “The study of Prostate cancer stem cells in prostate tissue and metastasis”Obertained Tianjin Science and Technology achievements.Registration No.20141566. And in 2018 completed the topic“Preparation of novel nano-drug targeting prostate cancer and the study of effects for anticancer”Obertained Tianjin Science and technology achievements Registration No.20180120.I have published over 10 papers coveraged by SCI with first author and correspondence author.I have presided over 3 research projects currently.

2. Educational Background

2003.8-2006.7 Peking Union Medical College.The department of urology.MD

2002.8-2003.7 The first Hospital of PekingUniversity.The department of urology.Visiting doctor.

1999.8-2002.7 Tianjin Medical University.Surgery.Master's degree.

1990.8-1995.7 Tianjin Medical University.Clinical medicine.Bachelor degree.

3. Work Experience

2006.9-2017.12 Tianjin First Central Hospital.The department of urology.Chief physician

1995.8-1999.7 Tianjin Children Hospital.Attending physician

4. Awards

Won the 2018 Tianjin Health and Family Planning Commission high-level talent project（RMB 1,200,000）

5. Social Service

The member of the Urology Branch of Chinese Medical Association.

The member of the Tianjin Urology Branch of Chinese Medical Association.

The member of the Tianjin Urology Branch of Association of Integrated Chinese and Western medicine

Achievements

The study of Prostate cancer stem cells in prostate tissue and metastasis.Registration No.20141566.

Preparation of novel nano-drug targeting prostate cancer and the study of effects for anticancer.Registration No.20180120.

Peer-Reviewed Journal Papers

1.Long wavelength excitablenearinfrared fluorescent nanoparticles with aggregationinduced emission characteristics for image-guided tumor resection.Chemical Science. 2017, 8, 2782-2789.(SCI 8.668)

2.Co-delivery of doxorubicin and curcumin by pHsensitive prodrug nanoparticle for combination therapy of cancer.Scientific Reports.2016,6(2122). (SCI5.228)

3.Supramolecular nanofibers of self-assembling peptides and proteins for protein delivery.Chemical Communications.2015,51(75）:14239-14242. (SCI6.834)

4.Biocompatible fluorescent supramolecular nanofibrous hydrogel for long-term cell tracking and tumor imaging applications.Scientific Reports.2015,5(16680）.(SCI 5.228)

5.Self-assembling peptide nanofibers containing D-amino acids for tetrandrine delivery.Current Signal Transduction Therapy.2015,10(2):83-88.(SCI 0.452)

Projects

2017.01-2020.12.Development of precise anticancer drugs with tumor-responsive enrichment feature for bladder perfusion chemotherapy.Project supported by the National Natural Science Foundation of China (Grant No. 51673150).RMB 610,000.

2016.01-2020.12.High throughput and high sensitivity pathology slide scanner.Major scientific research and instrument manufacture program of National Natural Science Foundation of China. (Grant No. 31527801).RMB 200,000.

2016.12-2019.11.Study of the active targeted infusion chemotherapy of new nano-chemotherapy drugs in bladder cancer.(Grant No. 16KG103).RMB 300,000.